Reproductive hormone levels and anthropometry in postmenopausal women with polycystic ovary syndrome (PCOS): A 21-year follow-up study of women diagnosed with PCOS around 50 years ago and their age-matched controls

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 7, 2011, Pages 2178-2185

  Schmidt, Johanna ^a   Brännström, Mats ^a   Landin Wilhelmsen, Kerstin ^a   Dahlgren, Eva ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; ESTRADIOL; ESTRONE; FOLLITROPIN; HORMONE; LUTEINIZING HORMONE; PRASTERONE SULFATE; PROLACTIN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; THYROID PEROXIDASE ANTIBODY; THYROTROPIN;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BODY MASS; BODY WEIGHT; CLIMACTERIUM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HIRSUTISM; HORMONE DETERMINATION; HUMAN; MENOPAUSE; OVARY POLYCYSTIC DISEASE; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; UNIVERSITY HOSPITAL; WAIST HIP RATIO;

ACETAZOLAMIDE; AGED; ANTHROPOMETRY; BODY COMPOSITION; CASE-CONTROL STUDIES; FEMALE; FOLLICLE STIMULATING HORMONE; FOLLOW-UP STUDIES; GONADAL HORMONES; HUMANS; LUTEINIZING HORMONE; MIDDLE AGED; POLYCYSTIC OVARY SYNDROME; POSTMENOPAUSE; PROLACTIN; PROSPECTIVE STUDIES; THYROTROPIN; WAIST-HIP RATIO;

EID: 79960101774     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2010-2959     Document Type: Article

References (35)

1. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO 2004 The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89:2745-2749 (Pubitemid 38766360)
2. March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ 2010 The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 25:544-551
3. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE, Witchel SF 2006 Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 91:4237-4245 (Pubitemid 44833391)
4. van Santbrink EJ, Hop WC, Fauser BC 1997 Classification of normogonadotropic infertility: polycystic ovaries diagnosed by ultrasound versus endocrine characteristics of polycystic ovary syndrome. Fertil Steril 67:452-458 (Pubitemid 27085957)
5. Rebar R, Judd HL, Yen SS, Rakoff J, Vandenberg G, Naftolin F 1976 Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome. J Clin Invest 57:1320-1329
6. Fauser BC, Pache TD, Lamberts SW, Hop WC, de Jong FH, Dahl KD 1991 Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease. J Clin Endocrinol Metab 73:811-817 (Pubitemid 21921942)
7. Yen SS 1980 The polycystic ovary syndrome. Clin Endocrinol (Oxf) 12:177-207 (Pubitemid 10175005)
8. Kumar A, Woods KS, Bartolucci AA, Azziz R 2005 Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS). Clin Endocrinol (Oxf) 62:644-649 (Pubitemid 40825931)
9. Polson DW, Franks S, Reed MJ, Cheng RW, Adams J, James VH 1987 The distribution of oestradiol in plasma in relation to uterine cross-sectional area inwomenwith polycystic or multifollicular ovaries. Clin Endocrinol (Oxf) 26:581-588 (Pubitemid 17052490)
10. Burger HG, Dudley EC, Hopper JL, Shelley JM, Green A, Smith A, Dennerstein L, Morse C 1995 The endocrinology of the menopausal transition: a cross-sectional study of a population-based sample. J Clin Endocrinol Metab 80:3537-3545
11. Burger HG, Dudley EC, Hopper JL, Groome N, Guthrie JR, Green A, Dennerstein L 1999 Prospectively measured levels of serum follicle-stimulating hormone, estradiol, and the dimeric inhibins during the menopausal transition in a population-based cohort of women. J Clin Endocrinol Metab 84:4025-4030 (Pubitemid 30644189)
12. Davison SL, Bell R, Donath S, Montalto JG, Davis SR 2005 Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab 90:3847-3853 (Pubitemid 41058142)
13. Burger HG, Dudley EC, Cui J, Dennerstein L, Hopper JL 2000 A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition. J Clin Endocrinol Metab 85: 2832-2838 (Pubitemid 32269161)
14. Laughlin GA, Barrett-Connor E, Kritz-Silverstein D, vonMühlen D 2000 Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo Study. J Clin Endocrinol Metab 85:645-651
15. Rozenberg S, Bosson D, Peretz A, Caufriez A, Robyn C 1988 Serum levels of gonadotrophins and steroid hormones in the post-menopause and later life. Maturitas 10:215-224
16. Longcope C, Franz C, Morello C, Baker R, Johnston Jr CC 1986 Steroid and gonadotropin levels in women during the peri-menopausal years. Maturitas 8:189-196.
17. Winters SJ, Talbott E, Guzick DS, Zborowski J, McHugh KP 2000 Serum testosterone levels decrease in middle age in women with the polycystic ovary syndrome. Fertil Steril 73:724-729 (Pubitemid 30154110)
18. Dahlgren E, Johansson S, Lindstedt G, Knutsson F, Odén A, Janson PO, Mattson LA, Crona N, Lundberg PA 1992 Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones. Fertil Steril 57:505-513
19. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group 2004 Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:19-25
20. Takahashi K, Ozaki T, Okada M, Uchida A, Kitao M 1994 Relationship between ultrasonography and histopathological changes in polycystic ovarian syndrome. Hum Reprod 9:2255-2258
21. Franks S 1989 Polycystic ovary syndrome: a changing perspective. Clin Endocrinol (Oxf) 31:87-120 (Pubitemid 19178148)
22. Wilhelmsen L, Johansson S, Rosengren A, Wallin I, Dotevall A, Lappas G 1997 Risk factors for cardiovascular disease during the period 1985-1995 in Goteborg, Sweden. The GOT-MONICA Project. J Intern Med 242:199-211 (Pubitemid 27400432)
23. Holte J, Bergh T, Gennarelli G, Wide L 1994 The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women. Clin Endocrinol (Oxf) 41:473-481 (Pubitemid 24301280)
24. Webber LJ, Stubbs S, Stark J, Trew GH, Margara R, Hardy K, Franks S 2003 Formation and early development of follicles in the polycystic ovary. Lancet 362:1017-1021 (Pubitemid 37186878)
25. Hudecova M, Holte J, Olovsson M, Sundström Poromaa I 2009 Long-term follow-up of patients with polycystic ovary syndrome: reproductive outcome and ovarian reserve. Hum Reprod 24:1176-1183
26. Rödström K, Bengtsson C, Milsom I, Lissner L, Sundh V, Bjoürkelund C 2003 Evidence for a secular trend in menopausal age: a population study of women in Gothenburg. Menopause 10:538-543 (Pubitemid 40228149)
27. Wild S, Pierpoint T, Jacobs H, McKeigue P 2000 Long-term consequences of polycystic ovary syndrome: results of a 31 year follow-up study. Hum Fertil (Camb) 3:101-105
28. Sowers MR, Zheng H, McConnell D, Nan B, Harlow S, Randolph Jr JF 2008 Follicle stimulating hormone and its rate of change in defining menopause transition stages. J Clin Endocrinol Metab 93: 3958-3964.
29. Mulders AG, Laven JS, Eijkemans MJ, de Jong FH, Themmen AP, Fauser BC 2004 Changes in anti-Mullerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility. Hum Reprod 19:2036-2042 (Pubitemid 39236470)
30. Tehrani FR, Solaymani-Dodaran M, Hedayati M, Azizi F 2010 Is polycystic ovary syndrome an exception for reproductive aging? Hum Reprod 25:1775-1781
31. Kumar A, Chaturvedi PK, Mohanty BP 2007 Hypoandrogenaemia is associated with subclinical hypothyroidism in men. Int J Androl 30:14-20 (Pubitemid 46161036)
32. Johnson NP, Wang K 2003 Is ovarian surgery effective for androgenic symptoms of polycystic ovarian syndrome? J Obstet Gynaecol 23:599-606
33. Puurunen J, Piltonen T, Jaakkola P, Ruokonen A, Morin-Papunen L, Tapanainen JS 2009 Adrenal androgen production capacity remains high up to menopause in women with polycystic ovary syndrome. J Clin Endocrinol Metab 94:1973-1978
34. Piltonen T, Koivunen R, Perheentupa A, Morin-Papunen L, Ruokonen A, Tapanainen JS 2004 Ovarian age-related responsiveness to human chorionic gonadotropin in women with polycystic ovary syndrome. J Clin Endocrinol Metab 89:3769-3775 (Pubitemid 39071470)
35. Mathur R, Braunstein GD 2010 Androgen deficiency and therapy in women. Curr Opin Endocrinol Diabetes Obes 17:342-349